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Abstract
The NSs proteins of bunyaviruses are the viral interferon antagonists, counteracting the host’s antiviral response to
infection. During high-multiplicity infection of cultured mammalian cells with Bunyamwera orthobunyavirus (BUNV), NSs is
rapidly degraded after reaching peak levels of expression at 12hpi. Through the use of inhibitors this was shown to be the
result of proteasomal degradation. A recombinant virus (rBUN4KR), in which all four lysine residues in NSs were replaced by
arginine residues, expresses an NSs protein (NSs4KR) that is resistant to degradation, confirming that degradation is lysine-
dependent. However, despite repeated attempts, no direct ubiquitylation of NSs in infected cells could be demonstrated.
This suggests that degradation of NSs, although lysine-dependent, may be achieved through an indirect mechanism.
Infection of cultured mammalian cells or mice indicated no disadvantage for the virus in having a non-degradable NSs
protein: in fact rBUN4KR had a slight growth advantage over wtBUNV in interferon-competent cells, presumably due to the
increased and prolonged presence of NSs. In cultured mosquito cells there was no difference in growth between wild-type
BUNV and rBUN4KR, but surprisingly NSs4KR was not stabilised compared to the wild-type NSs protein.
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Introduction
Bunyamwera virus (BUNV) is the type species of both the family
Bunyaviridae and the genus Orthobunyavirus. This family contains
pathogens of serious concern such as Rift Valley fever virus and
Crimean-Congo haemorrhagic fever virus. BUNV itself is of low
pathogenicity ([1]), but the recent outbreak of Schmallenberg
orthobunyavirus in Europe ([2]) underscores the pathogenic
potential of the orthobunyaviruses and the economic damage
these viruses can cause. All members of the Bunyaviridae except
those in the Hantavirus genus are transmitted by arthropods.
Bunyaviruses possess a trisegmented RNA genome of negative or
partially ambisense polarity that is encapsidated by nucleoprotein
(N) and bound to the viral RNA polymerase (L), and is enveloped
in a host-derived membrane containing the viral glycoproteins.
Orthobunyaviruses encode the viral RNA polymerase on the large
(L) genome segment, a polyprotein precursor on the medium (M)
segment, and the N protein and a nonstructural protein (NSs), in
overlapping reading frames, on the S segment. The M segment-
encoded polyprotein is co-translationally cleaved to yield the
mature glycoproteins Gn and Gc as well as a second nonstructural
protein, NSm ([3]). The NSs protein is the viral interferon (IFN)
antagonist ([4], [5], [6]) but has also been implicated in other
functions such as regulation of translation, apoptosis, and viral
polymerase activity ([7], [8–11]).
The observation that the levels of NSs protein decline rapidly
after 12 hours post infection (hpi), whereas the rate of de novo
synthesis remains unchanged during this time ([8,12,13]), suggest-
ed that NSs is subject to active targeted proteasomal degradation.
Proteins are targeted for proteasomal degradation by covalent
attachment of multiple ubiquitin molecules (ubiquitylation) at
lysine (K) residues. The three-step ubiquitylation reaction involves
the E1 activating enzyme, an E2 conjugating enzyme and an E3
ligase complex. The E3 ligases are the components that confer
specificity on this system by recognising the target proteins ([14]).
The ubiquitin-proteasome system (UPS) is involved in host anti-
viral defenses by regulating the degradation or activation of crucial
factors, and viruses have evolved mechanisms either to block these
signals or to subvert the UPS to cause degradation of anti-viral
factors ([15–20]). In other cases, viruses have been found to
require a functional UPS for specific steps in their replication cycle
such as entry ([21,22]), nuclear export ([23]), budding ([24]),
genome transcription/translation/replication ([25–27]) or general
virus replication ([28–33]). Given these extensive interactions of
viruses from diverse families with the UPS some involvement of
this system in the BUNV replication cycle could also be expected.
We present here an analysis of the degradation of NSs and the
effect of mutations that prevent this degradation. Both the use of
proteasome inhibitors and mutation of the lysine residues in NSs to
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arginine residues resulted in accumulation of NSs, suggesting that
NSs is targeted for proteasomal degradation through ubiquityla-
tion. Interestingly, a recombinant virus that expresses an NSs
protein lacking lysine residues behaved almost indistinguishably
from wild-type (wt) virus in infection of both cultured mammalian
cells and mice, displaying only a very slight growth advantage in
interferon-competent A549 cells. Surprisingly, in mosquito cells
the mutant NSs4KR protein was even less stable than wt NSs,
suggesting the involvement of an alternative degradation mech-
anism.
Results
Degradation of NSs is proteasome-mediated and lysine-
dependent
During high-multiplicity infection of BHK cells with wtBUNV,
NSs protein levels increased up to 12hpi and then decreased to
below detection limits by 24hpi, whereas N protein levels reached
a plateau from approximately 12hpi (Fig. 1 A, left panel). Since N
and NSs are translated from overlapping ORFs on the same
mRNA, this suggested that NSs was actively degraded during
infection. Treating infected cells with the proteasome inhibitor
MG132 prevented degradation and led to considerable accumu-
lation of NSs (Fig. 1A, middle panel). MG132 also blocks
lysosomal proteases and therefore infected cells were treated with
the more specific proteasome inhibitor epoxomicin (Fig. 1A, right
panel). This resulted in accumulation of NSs to a similar extent as
with MG132 treatment, confirming that NSs is indeed subject to
proteasomal degradation.
Proteasomal protein degradation is regulated through ubiqui-
tylation of the substrate at lysine (K) residues. BUNV NSs has 4
lysine residues, at amino acid (aa) positions 39, 44, 49 and 54.
Although these residues are not conserved in all the NSs proteins
encoded by viruses in the Orthobunyavirus genus, the lysine residue
at position 44 is completely conserved in viruses of the
Bunyamwera serogroup. Using reverse genetics we generated a
virus in which all four lysine residues were mutated to arginine (R),
without affecting the sequence of the overlapping N protein. The
mutant virus was called rBUN4KR and the mutant protein
NSs4KR.
In BHK cells infected with the mutant virus, the NSs4KR
protein was greatly stabilised (Fig. 1B), reaching levels similar to
those seen for wt NSs in wtBUNV infected cells treated with
MG132 (compare Fig. 1A). The increased stability of NSs4KR
suggested that modification of wt NSs at one or more of the lysine
residues, most likely by ubiquitylation, is involved in its degrada-
tion. Four additional recombinant mutant viruses were created in
which the four arginine residues in rBUN4KR were individually
mutated back to lysine (called rBUN-K1 to K4; Fig. 1C). When
BHK cells were infected with these viruses, all the single-lysine
NSs proteins were subject to degradation (Fig. 1D). The NSs
protein containing a lysine residue at position 49 (rBUN-K3) was
only partially degraded after 24 hours, indicative of slower
processing. This would agree with structure predictions (Jpred,
http://www.compbio.dundee.ac.uk/www-jpred), that place this
Figure 1. Degradation of NSs. BHK cells were infected at 5 PFU/cell and harvested at the indicated times post infection (top of blots) and cell
lysates were analysed by immunoblotting using antibodies against the proteins indicated to the right of the panels (tub = tubulin). (A) Effect of
proteasome inhibitors. Cells were mock-infected or infected with wtBUNV and either left untreated or treated with MG132 (10 mM) or Epoxomicin
(200 nM) from 5 hpi until harvest. (B) Expression of 4KRNSs. Cells were mock-infected or infected with wtBUNV or rBUN4KR. (C) Schematic overview of
the NSs proteins of recombinant viruses expressing NSs proteins containing a single lysine at one of the four positions (K1-K4). (D) Expression of NSs
containing single lysine residues. Cells were mock-infected or infected with wtBUNV, rBUN4KR, or rBUN-K1, -K2, -K3 and -K4. m= mock-infected; wt =
wtBUNV; 4KR = rBUN4KR.
doi:10.1371/journal.pone.0064137.g001
Bunyamwera Virus NSs Protein
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lysine residue in a less solvent-accessible position in the protein and
thus less available for modification (Rob Hagan, personal
communication). Taken together these results strongly suggest
that NSs is subject to proteasomal degradation and that any of the
four lysine residues could be used to target NSs to the proteasome.
Ubiquitylation of NSs
Med8 is part of the mediator complex that regulates cellular
RNA polymerase II (RNAPII) activity, and in addition can form a
Cullin-RING E3 ubiquitin ligase complex together with Elongins
B and C (EloB, EloC), Cullin2 (Cul2) and RING-box protein 1
(Rbx1) ([34]). Med8 has previously been reported to interact with
BUNV NSs ([35]), and thus Med8 was the prime candidate for the
E3 ligase that targets NSs for degradation. Cullin-RING ligases
require activation through neddylation to form active E3 ligase
complexes ([36]). This activation is accomplished by NEDD8-
activating enzyme (NAE) which can be blocked by using the
inhibitor MLN4924 ([37]). A549 cells treated with this inhibitor
indeed showed greatly reduced levels of neddylated Cullins
(Fig. 2A). However, in contrast to the effects of MG132, treating
BUNV-infected cells with MLN4924 did not stabilise NSs
(Fig. 2A), indicating that NSs degradation is not regulated through
Cullin-RING E3 ubiquitin ligases. This excluded the possibility
that NSs degradation is mediated by the Med8-containing E3
ligase.
To elucidate further the mechanism of NSs degradation,
infected BHK cells were treated with PYR-41, an inhibitor of
ubiquitin activating enzyme E1 (UAEI; ([38]); Fig. 2B). If
ubiquitylation was required for NSs degradation, blocking E1
should have a stabilising effect on NSs. Indeed, PYR-41 treatment
did result in stabilisation of NSs (Fig. 2B), although apparently to a
lower extent than observed with MG132 (compare Fig. 1A). On
closer examination the drug appeared to have an overall inhibitory
effect on viral protein expression. When PYR-41 was added an
hour prior to or just after infection of the cells, no or only very little
N protein could be detected by 24hpi (not shown), confirming a
general inhibitory effect of the drug on BUNV replication. Thus,
the drug seemed to inhibit viral protein synthesis in addition to
blocking degradation of NSs, indicating that NSs degradation does
indeed require ubiquitylation.
Since all the evidence presented above pointed towards a
classical ubiquitylation-proteasomal degradation pathway for NSs,
efforts were made to demonstrate directly the existence of
ubiquitylated NSs protein. In vitro ubiquitylation assays ([17])
failed to show the generation of any higher molecular weight
species of NSs (data not shown). In vivo ubiquitylation was
investigated using an A549-derived cell line expressing 66His-
tagged ubiquitin, A549-6His-Ub. The cells were infected with
wtBUNV and treated with MG132. The presence of ubiquitylated
NSs was investigated by passing cell lysates over Ni2+-resin, but no
bound NSs was detected (data not shown). NSs expression levels
were estimated to be ,25–50 times lower in A549 cells compared
to BHK cells, which might result in the levels of ubiquitylated NSs
being below the detection limits for this method. It should also be
noted that no higher molecular weight species were detected by
western blotting with our anti-NSs antibody of lysates of infected
BHK, A549, or A549-6His-Ub cells, whether or not the cells were
treated with inhibitors.
In summary, although degradation of NSs was found to be
dependent on an active UPS, it was not possible to confirm
ubiquitylation of NSs directly.
Effect of the 4KR mutations on known functions of NSs
One of the functions of NSs is to block apoptosis, as a virus
deficient in NSs expression, rBUNdelNSs2, was shown to be a
potent inducer of programmed cell death ([9]). In order to study
the effect of the mutant NSs4KR on induction of apoptosis,
infected cells were subjected to DNA fragmentation analysis
(Fig. 3A). Although all infected cells showed some degree of DNA
laddering compared to the mock-infected cells, this was barely
detectable in cells infected with wt BUNV or rBUN4KR, whereas
rBUNdelNSs-infected cells showed a bright smear of fragmented
DNA as early as 12hpi (Fig. 3A).
Another reported function of NSs is to regulate the viral RNA
polymerase activity, as demonstrated by the inhibitory effect of co-
expression of NSs in a minireplicon assay ([11]). Therefore, we
examined whether the lysine-to-arginine mutations in NSs4KR
affected its ability to control the viral polymerase. When NSs4KR
was co-expressed in the minireplicon assay, it displayed the same
dose-dependent inhibitory effect as co-expression of wt NSs
protein (Fig. 3B), indicating that the lysine residues in NSs were
not required for the polymerase-regulating function.
Regulation of the viral polymerase by NSs could be important
for reducing the generation of defective interfering particles (DIs),
which contain truncated copies of the viral genome segments
([12,39]) and could act as strong IFN inducers ([40]). To
investigate whether NSs stability was related to DI formation,
wtBUNV, rBUN4KR and rBUNdelNSs2 were serially passaged in
BHK cells, starting at 5 PFU/cell and using a fixed volume of the
infectious supernatant thereafter. After 8 passages (P8; or P7 for
rBUNdelNSs2) the RNA was extracted from pelleted virions and
analysed by Northern blotting with an L segment-specific probe
(Fig. 3C). All three viruses had acquired smaller L-segment-
derived RNA species, characteristic of DI RNAs ([39]), indicating
that increased and prolonged expression of NSs does not prevent
DI formation during passage in BHK cells. Both the rBUN4KR
Figure 2. Effect of ubiquitin ligase E3 and E1 inhibitors on NSs
degradation. Cells were infected at 5 PFU/cell and harvested at the
indicated times post infection (top of blots) and cell lysates were
analysed by immunoblotting using antibodies against the proteins
indicated to the right of the panels. (A) Effect of E3 inhibitor. A549 cells
were mock-infected or infected with wtBUNV and left untreated (2) or
treated with MG132 (10 mM; MG) or MLN4924 (1 mM; MLN) from 5 hpi
until harvest. (B) Effect of E1 inhibitor. BHK cells were mock-infected (m)
or infected with wtBUNV and left untreated (2) or treated with PYR-41
(50 mM) from 8 hpi.
doi:10.1371/journal.pone.0064137.g002
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and rBUNdelNSs2 virus had accumulated relatively larger
amounts of DI RNAs than wtBUNV whereas the relative levels
of full-length L segment of these viruses were below the detection
limit in these experimental conditions. We define the PFU-
equivalent as the number of PFUs used to extract a certain amount
of RNA. The amount of full-length L segment would be expected
to correlate with the amount of PFUs since these require a
functional polymerase. Thus, for rBUN4KR P0 more PFU-
equivalents were loaded onto the gel than for wtBUNV P0 (108 v
106.5) and the signal for full length L segment is correspondingly
stronger and seems to be proportional to the PFU-equivalent. For
the P8/P7 samples, due to volume constraints only relatively low
PFU-equivalents were loaded and this seemed to correlate with a
low signal for full-length L segment for wt BUNV and the absence
of this signal for the rBUN4KR and rBUNdelNSs2 viruses.
The titres of infectious virus released into the medium varied
considerably with the different passages (Fig. 3D). As the cells were
inoculated with fixed volumes at each passage, the m.o.i. for each
infection also varied markedly. Interestingly, despite the presence
of large amounts of DI RNAs at P8/P7 all viruses grew to titres in
the range 106–107 PFU/ml at P9/P8.
Viral RNA of passage 10 (P10) was extracted from pelleted
virions and the S segments were amplified by RT-PCR followed
by sequence analysis. The S segment of rBUN4KR had retained
its K-to-R mutations and no mutations were found in the
wtBUNV S segment. Interestingly, the S segment of rBUN-
delNSs2 had acquired the GTG-to-ATG mutation at NSs codon
22 that had been observed previously ([13]).
Stabilised NSs expression provides a growth advantage
in IFN-competent mammalian cells
In order to study the effect of stabilisation of NSs during virus
replication, the growth kinetics of wtBUNV and rBUN4KR were
compared in IFN-competent (A549) and IFN-incompetent (BHK
and A549-V) cells. In both BHK and A549-V cells (Fig. 4A and B,
respectively), rBUN4KR behaved almost indistinguishably from
wt BUNV. In naı¨ve A549 cells, however, the mutant virus reached
titers of 2.76108 PFU/ml whereas wt virus grew to 2.86107 PFU/
ml (Fig. 4C). This difference suggests that the increased and
prolonged presence of NSs in rBUN4KR conferred a growth
advantage in IFN competent cells. Interestingly, this growth
advantage was not observed when the infections were incubated at
33uC (Fig. 4E). At this temperature, rBUN4KR and wtBUNV
displayed similar growth characteristics in both BHK and A549
cells (Fig. 4D and E, respectively).
Figure 3. Effect of NSs4KR mutations on known functions of NSs. (A) Induction of apoptosis in infected cells as measured by DNA
fragmentation. A549 cells were mock-infected or infected with wtBUNV, rBUN4KR, or rBUNdelNSs2. Cells were harvested at 12, 24, and 48 hpi and
analysed for DNA fragmentation. (B) Regulation of the viral polymerase in a minireplicon assay. Increasing amounts of plasmids (1.6–160 ng)
expressing wt NSs or NSs4KR or a nonrelated protein (GFP) were added to a minireplicon assay expressing the viral minigenome (expressing Renilla
luciferase), viral polymerase and nucleoprotein. Values shown are from quadruplicate measurements and represent Renilla luciferase activity over
firefly luciferase activity, normalised to the control reaction. (C) Generation of defective RNAs. wtBUNV, rBUNdelNSs2, and rBUN4KR viruses were
serially passaged at a fixed volume in BHK cells. Virions from the virus stock (P0) and passage 8 (P8; or P7 for rBUNdelNSs2) were pelleted and their
extracted RNA was analysed by Northern blotting using a probe to detect genome-sense L RNA. All lanes are from the same exposure of the same
Northern blot. Positions of size markers (in kb) are indicated to the left, and the amount of RNA and PFU-equivalents (log(pfu)) loaded are indicated
below the blot. (D) Titres of the viruses at each passage.
doi:10.1371/journal.pone.0064137.g003
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To understand why this difference in growth was observed only
at 37uC, we examined IFN production in A549 cells at both
temperatures. Cells were either treated with poly(I:C) or infected
with rBUNdelNSs2, a potent IFN inducer ([6]), for 24 h. In a
protection assay on A549-NPro cells, the relative IFN content of
the supernatants from the treated or infected cells was measured
by monitoring the number of 2-fold dilutions of supernatant that
protected the cells from subsequent infection by IFN-sensitive
EMCV. Both poly(I:C) treatment and rBUNdelNSs infection
induced about twice as much IFN at 37uC as at 33uC, but virus
infection appeared to be a much stronger inducer than the dsRNA
analogue (Fig. 4F). When cells were infected with either wtBUNV
or rBUN4KR, no IFN could be detected in the supernatant (not
shown), indicating that both viruses were successful in blocking the
IFN response. Thus, while wtBUNV was capable of overcoming
the IFN response at either temperature, this appeared to come at a
slight fitness cost at 37uC, whereas rBUN4KR grew with equal
efficiency at both temperatures.
Virulence in mice is not significantly altered with
rBUN4KR virus
Since the mutant rBUN4KR virus appeared more capable to
counteract the IFN response in A549 cells, we examined whether
the 4KR mutations also led to increased virulence in mice. To this
end, 129-strain mice were infected intracranially (i.c) with
wtBUNV or rBUN4KR (Fig. 5) and monitored for up to two
weeks. Similar to previous observations ([4,41]), wtBUNV-infected
mice died at 4–6 dpi. The rBUN4KR-infected mice died at a
similar rate to wtBUNV-infected mice, demonstrating that
expression of the stabilised NSs protein did not alter the virulence
of the virus in this mouse model.
Virus replication in mosquito cells
Since the mutations in rBUN4KR that prevented degradation
of NSs did not seem to affect replication of the virus in a negative
way either in mammalian cells or in mice, we investigated whether
the lysine residues in NSs may be important for some aspect of the
virus replication cycle in mosquito cells. Aedes albopictus-derived
C6/36 and U4.4 cells, and Aedes aegypti-derived Ae cells were
infected with wtBUNV or rBUN4KR at 0.01 PFU/cell and the
titres of released virus were measured over time (Fig. 6A–C). The
growth kinetics of both viruses were similar in the same cells, but
the viruses replicated more efficiently in the A. albopictus cells than
in the A. aegypti cells.
Figure 4. Virus growth and IFN induction in cultured mammalian cells. (A–E) Multicycle growth kinetics of wtBUNV and rBUN4KR were
compared in BHK (A, D), A549 (C, E) and A549-V (B) cells by infecting triplicate wells at 0.01 PFU/cell and titrating the supernatants at the indicated
time points. A–C: incubation at 37uC; D, E: incubation at 33uC. (F) Induction of IFN by treatment with poly(I:C) or infection with rBUNdelNSs2. A549
cells were incubated at 33uC or 37uC and the supernatants assayed after 24 h. The amount of IFN produced is expressed as relative IFN units (RIU),
defined as RIU = 2N where N= the number of two-fold dilutions of the supernatants that protected the reporter cells from EMCV challenge (see
methods).
doi:10.1371/journal.pone.0064137.g004
Figure 5. Virulence in mice. Assessment of wtBUNV and rBUN4KR
virulence in mice. Strain 129 mice were infected i.c. with 1000 PFU of
wtBUNV or rBUN4KR virus. The mice were monitored twice daily and
sacrificed when moribund.
doi:10.1371/journal.pone.0064137.g005
Bunyamwera Virus NSs Protein
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Viral protein expression was analysed in C6/36 cells infected
with 5 PFU/cell (Fig. 6D, E). Both viruses produced easily
detectable levels of N protein by 24 hpi. The rate of synthesis of
NSs as compared to N protein during wtBUNV infection had
previously been shown to be significantly lower in C6/36 cells
than in BHK cells ([12]). Accordingly, detection of NSs protein by
WB was more difficult in mosquito cells than in BHK cells,
requiring significantly longer exposure times. In wtBUNV-infected
C6/36 cells NSs protein levels peaked at 24 hpi, and were barely
detectable by 76 hpi (Fig. 6D). The NSs4KR protein seemed to
peak at the same time during infection, but at lower levels than wt
NSs (Fig. 6E). Since mosquito cells have a UPS similar to that in
mammalian cells ([42,43]), the effect of proteasome inhibitors was
also tested in these cells. Addition of MG132 to infected cells for
8 h prior to harvest did increase the levels of NSs observed in
wtBUNV infected cells (Fig. 6D), confirming that NSs is degraded
by the proteasome in mosquito cells. Addition of MG132 seemed
to have only very little effect on the levels of NSs4KR, as would be
expected.
Taken together, the results showed that the mutations in
NSs4KR had no effect on virus growth in different mosquito cell
lines, and that the mutant protein did not accumulate to higher
levels than the wt protein. The reasons for the levels of NSs4KR
remaining significantly below those of wtNSs in mosquito cells
remain unclear.
Discussion
We have demonstrated here that during BUNV infection of
mammalian cells the NSs protein is actively targeted for
proteasomal degradation. This degradation requires a functional
UPS, as well as at least one lysine residue in NSs. Although these
findings strongly suggest that NSs is ubiquitylated, this modifica-
tion could not be demonstrated either in vitro or in vivo. Failure to
demonstrate NSs ubiquitylation in vitro may be indicative of
temporal regulation of this process during the infection cycle,
which may be difficult to replicate in a cell-free lysate. Successful
detection of NSs by Western blotting depends on the multiplicity
of infection and the time post infection that the samples are taken,
as well as the type of host cells supporting the infection. For
instance, the levels of viral proteins appeared to be overall lower in
A549 cells than in BHK cells. Treating cells with MG132 leads to
accumulation of NSs, making it easier to detect, and it would be
expected that proteasome inhibition would lead to detection on
Western blots of higher molecular-weight species corresponding to
ubiquitylated NSs. However, these have not been observed.
Possibly the turnover rate of ubiquitylated NSs by de-ubiquitinat-
ing enzymes is high, leaving only undetectably low levels of
ubiquitylated NSs in the cell lysates. However, adding a de-
ubiquitinase inhibitor to infected His6-ubiquitin expressing cells
did not aid detection of modified NSs in the pull-down assays (not
shown). At present, therefore, ubiquitylation of NSs can be neither
demonstrated nor excluded.
An alternative explanation for the lack of detectable ubiquity-
lated NSs might be that it is not NSs itself that is modified, but
rather some putative interacting partner. The ubiquitylated
partner through its association with NSs could direct NSs for
degradation. If this were the case, substitution of the lysine residues
in NSs for arginine residues could result in disturbance of the
structure of NSs that could weaken or prevent its interaction with
the partner, thus rendering NSs resistance to degradation. Future
work will examine this possibility.
NSs interacts with Med8, a component of the Mediator
complex that regulates RNAPII activity, and this interaction is
thought to be involved in the NSs-mediated inhibition of cellular
transcription ([35]). Med8 can also be part of an E3 ligase ([34]),
which made it a prime candidate for the potential E3 ligase that
targets NSs for degradation. However, treatment of infected cells
with MLN4924 did not stabilise NSs, indicating that no Cullin-2-
Figure 6. wtBUNV and rBUN4KR infection of mosquito cells. (A–C) Virus growth in mosquito cells. Triplicate wells of C6/36, U4.4, or Ae cells
were infected at 0.01 PFU/cell and supernatants analysed by plaque assay titration. (D, E) Expression of NSs protein. C6/36 cells were infected with
wtBUNV (D) or rBUN4KR (E) at 5 PFU/cell, and left untreated or treated with MG132 for 8 h prior to harvesting. Cell lysates were analysed by
immunoblotting using antibodies against the proteins indicated to the right. Above the lanes, m = mock; numbers are hpi.
doi:10.1371/journal.pone.0064137.g006
Bunyamwera Virus NSs Protein
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based ligases were involved in its degradation and thus ruling out
the possible involvement of Med8 as the E3 ligase recognising NSs.
In the experiments described above the inhibitors MG132,
epoxomicin and PYR-41 were added at 5–8 hpi, to allow N
protein synthesis to commence before treatment. When added
from the start of infection, the proteasome inhibitor MG132 and
the E1 inhibitor PYR-41 significantly delayed onset of N protein
production (by more than 12 h; data not shown). This is an
indication that, like many other viruses, BUNV requires an active
UPS during the early stages of infection.
Serial passage of wtBUNV, rBUN4KR and rBUNdelNSs2 in
BHK cells revealed that both mutant viruses accumulated
significantly more non-full-length L segment-derived RNAs,
presumed DI RNAs, than the wt virus. This could indicate a
subtle role for NSs in regulation of the viral polymerase, perhaps as
a quality control mechanism, such that either the lack of NSs or
the over-expression of NSs could both result in increased DI
production. Experiments are currently underway to test this
hypothesis.
Why is NSs degraded during infection of mammalian cells? All
the assays that test reported roles of NSs showed the non-
degradable NSs4KR mutant protein to function at least as well as
the wt NSs protein, if not better. In infected A549 cells, the mutant
virus with stabilised NSs had a slight growth advantage over wt
virus at 37uC, presumably as a result of increased and prolonged
expression of the viral interferon antagonist. This finding
demonstrated that the arginine substitutions did not impair the
interferon antagonist function of NSs. In interferon-deficient
A549-V or BHK cells no difference was observed in growth
kinetics between mutant rBUN4KR and wtBUNV. In mice, both
viruses were equally virulent, killing the mice in 4–6 days p.i.,
demonstrating that expressing a stabilised IFN antagonist did not
make the virus more virulent. The lack of any negative effect of the
4KR mutations on virus growth in mammalian cells or virulence
in mice suggested that perhaps the lysine residues in NSs could be
important for a role during infection of the mosquito vector.
In mosquito cells, BUNV infection does not result in shut-off of
host cell metabolism, and the NSs protein is expressed at
comparatively lower levels than in mammalian cells ([12]).
However, production of NSs is required for efficient replication
in certain mosquito cell lines and in mosquitoes ([44]). Analysis of
virus yields showed no difference in growth between wtBUNV and
rBUN4KR in each of three mosquito cell lines, indicating that in
these cells the absence of lysine residues in NSs did not impair
virus growth.
Contrary to expectation, in A. albopictus C6/36 cells NSs4KR
was not stabilised, and the protein could only be detected by WB
relatively early in infection (24hpi) when cells were infected at high
multiplicity. Unlike wt NSs the mutant protein could not be
stabilised by treatment with MG132 and therefore degradation of
NSs4KR in C6/36 cells would seem to be due to proteases that
recognise motifs that are absent in wt NSs. In addition, the levels
of NSs4KR expressed during infection were significantly lower
than those of wt NSs whereas the levels of N protein were similar,
indicating that the levels of mRNA produced by the two viruses
were similar. The only difference between the S segment-derived
mRNAs is the four nucleotides in the middle of the coding region
that change the four lysine residues to arginines in the NSs ORF.
A possible explanation for the lower levels of NSs4KR could
therefore lie in different rates of synthesis between wt and mutant
protein as a result of the relative abundance of the required tRNAs
(for lysine codons AAA or AAG compared to arginine codons
AGA or AGG). The relative usage of the arginine codons that
were introduced into NSs4KR is quite low in mosquito cells (6 and
4 per 1000 versus 11 and 11 per 1000 in BHK cells; (http://www.
kazusa.or.jp/codon/cgi-bin/showcodon.cgi?species = 7160;
http://www.kazusa.or.jp/codon/cgi-bin/showcodon.
cgi?species = 10036), but is considerably higher in the BUNV
genome itself (23 and 9 per 1000). This usage is even higher in the
ORF of the NSs4KR mutant (equivalent to 59 and 29 per 1000),
which could be a cause of the lower levels of protein synthesis
observed. However, because these numbers relate to usage per
1000 codons and as the NSs ORF is only 102 codons long, in
absolute numbers translation of the 4KR NSs protein requires
only two more of the lower-usage tRNAs than the wt NSs protein.
Metabolic labelling followed by immunoprecipitation to investi-
gate the relative rates of synthesis of the two NSs proteins in
mosquito cells yielded signals that were too low to get reliable
quantification (not shown). Furthermore, due to the overlapping
reading frame of the N protein, three out of the four lysine codons
of NSs could not be mutated to any other, more abundantly used,
arginine codons to investigate this matter further.
In summary, we have generated a mutant virus expressing a
stabilized NSs protein with thus far only one observed phenotype:
slightly enhanced growth in A549 cells at 37uC. The lysine
mutations did not appear to affect the assayable functions of NSs
in mammalian cells, or the ability of the mutant virus to replicate
in Ae. albopictus U4.4 and Ae. aegypti Ae cells which have a
requirement for NSs expression ([44]). Further studies are in
progress to determine whether rBUN4KR shows any phenotype
in live mosquitoes.
Materials and Methods
Cells and viruses
Vero-E6, BHK, BSR-T7/5 ([45]; kindly provided by K. K.
Conzelmann), A549 and A549-NPro ([46]; kindly provided by R.
Randall) cells were maintained as described previously
([35,44,46]). A549-V cells, stably transformed with the V protein
of parainfluenza virus type 5 to block interferon signalling
(unpublished), were also provided by R. Randall, and maintained
in Dulbecco’s minimal essential medium (DMEM) supplemented
with 10% fetal calf serum (FCS). A549-6His-Ub cells constitutively
expressing 6His-tagged ubiquitin (unpublished) were generously
provided by Dr B. Hale, and were maintained in DMEM
supplemented with 10% FCS. Mosquito cell lines C6/36 and U4.4
from Aedes albopictus and Ae from Aedes aegypti were maintained as
described by [44]. Stocks of wtBUNV, rBUNdelNSs2, and of the
mutant rBUNNSs4KR described here, were prepared as de-
scribed previously following plaque purification ([35]). The
recombinant viruses expressing single-lysine mutants of NSs,
rBUNK1, rBUNK2, rBUNK3 and rBUNK4 were not plaque-
purified, but working stocks were grown by infecting BHK cells
with rescue supernatants.
Plasmids
Plasmids containing full-length cDNAs of BUNV genome
segments or the minigenome under control of T7 promoter and
terminator sequences (pT7ribo-BUNL(+), pT7ribo-BUNM(+),
pT7ribo-BUNS(+) and pT7ribo-BUNMRen) and pTM-1 derived
plasmids expressing NSs, N or L (pTM1-NSs, pTM1-N, pTM1-L)
have been described previously ([11,47]). pTM1-NSs and
pT7ribo-BUNS(+) were mutated to change the 4 lysine residues
in NSs to arginine residues by Quickchange PCR mutagenesis to
create the 4KR versions. The plasmids were amplified using KOD
polymerase (Novagen) and primers ivk69 and ivk70. After 18
cycles of PCR amplification the template was destroyed by
incubation with DpnI (Fermentas) and the products were
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transformed into E. coli JM109. A similar procedure, using 4KR
versions of the plasmids as template, was used to generate the
related plasmids expressing NSs-K1 (primers ivk86 and ivk87), -
K2 (primers ivk88 and ivk89), -K3 (primers ivk90 and ivk91) and -
K4 (primers ivk92 and ivk93) constructs. All primers are listed in
Table 1.
Virus rescue
Viruses were rescued as described before ([48]). Briefly, 60 mm
dishes of subconfluent BSR-T7/5 cells were transfected, using
Lipofectamine-2000, with 1 mg each of pT7ribo-plasmids express-
ing the three viral RNA segments. The transfected cells were
incubated at 33uC until CPE was observed.
Virus Infection
Viruses were diluted in PBS containing 2% newborn calf serum
such that the minimum infection volume (200 ml for a 35-mm dish)
contained the required amount of virus for the intended m.o.i.
Multi-cycle infections for growth curves were inoculated at m.o.i.
0.01, and single-cycle infections for protein analysis at m.o.i. 5.
Cells were infected with virus at 37uC (or 33uC where indicated)
for 1 h and the inoculum was replaced with fresh growth medium
at t = 1 hpi. For growth curves the supernatants were harvested,
clarified by centrifugation at 5006g for 5 min, and stored at
280uC before titration by plaque assay.
Where indicated drugs were used as follows: to block the
proteasome the medium on the cells was replaced at 5–6 hpi by
medium containing 10 mM MG132 (Calbiochem) or 200 nM
Epoxomicin (Sigma), which was left on until harvest. The inhibitor
of the E1 ubiquitylation enzyme, PYR-41 (Merck), was used at
50 mM and added at 8 hpi. The NEDD8 E1 activating enzyme
inhibitor MLN4924 (kindly provided by Prof. R.T. Hay) was used
at 1 mM, and added at 5–6 hpi.
Plaque assay
The plaque phenotype of viruses and the titres of growth curve
and passaging assay samples were determined by plaque assay.
Vero-E6 cells were infected with serial dilutions of the samples,
and after 1 h incubation at 37uC an overlay of 0.6% agarose and
2% FBS in 1xMEM with was applied. Cells were incubated at
37uC for 5 days and then fixed in 4% formaldehyde for 3 hours
before staining with Giemsa stain.
Biological assay for interferon production
A549 cells in 35 mm dishes were infected with 3 PFU/cell of
rBUNdelNSs2 or transfected with 1 mg poly(I:C) and incubated at
either 33uC or 37uC for 24 h. After virus inactivation two-fold
serial dilutions of the medium were applied to fresh A549-NPro
cells for 24 h. IFN-sensitive encephalomyocarditis virus (EMCV)
was then added (0.05 PFU/cell), and cells incubated for 4 days at
37uC. The cells were fixed with formaldehyde and stained with
Giemsa stain to monitor development of CPE. The relative IFN
units (RIU) are expressed as 2N where N is the number of two-fold
dilutions that protect the reporter cells.
Passaging assay
T25 flasks of BHK cells were infected initially with 5 PFU/cell
of wtBUNV, rBUN4KR, or rBUNdelNSs2. The supernatant was
harvested when clear signs of CPE were observed. Subsequent
passages were performed ‘blind’ (without titrating the viruses): new
flasks were infected with a fixed volume of 0.3 ml virus per flask
and harvested when CPE was observed or at 3–4 dpi. The
supernatants were collected, clarified, and stored at 280uC.
Minireplicon assay
To measure viral RNA polymerase activity plasmids expressing
all the components of an RNP (viral RNA, N protein, L protein)
Table 1. Primers used in this study.
Primer Name
Aligns to
BUNS(+)
nts Sequence 59–.39
ivk01 S-Fw
mut
1–46* AGTAGTGTACTCCACCTAAAACTTATGCTATTGTTGAAAATCGCTG
ivk02 S-Rv mut 936–912* CAGTTCTCGAGCATCAAATACCATTAACAATATAATGTTG
ivk20 NSs-start
Fw
104–126* GGGAAACGTCTCaCATGATGTCGCTGCTAACACCAG
ivk55 39UTR Rv 892–846* TCGAGTGTCCCCAACCACCCACCCAAGCAGCTGTTATTTTGTGGGTTGAAAC
ivk69 4KR-
Fw
211–278 CTACATTAAgGGACGCGAGATTAAgACTAGTCTCGCAAAgAGAAGTGAATGGGAgGTTACACTTAACC
ivk70 4KR-
Rv
273–203 AGTGTAACcTCCCATTCACTTCTcTTTGCGAGACTAGTcTTAATCTCGCGTCCcTTAATGTAGAAGATTCG
ivk86 K1-F 211–237 CTACATTAAaGGACGCGAGATTAAGAC
ivk87 K1-R 237–211 GTCTTAATCTCGCGTCCtTTAATGTAG
ivk88 K2-F 220–246 GGGACGCGAGATTAAaACTAGTCTCGC
ivk89 K2-R 246–220 GCGAGACTAGTtTTAATCTCGCGTCCC
ivk90 K3-F 235–263 GACTAGTCTCGCAAAaAGAAGTGAATGGG
ivk91 K3-R 263–235 CCCATTCACTTCTtTTTGCGAGACTAGTC
ivk92 K4-F 250–278 GAGAAGTGAATGGGAaGTTACACTTAACC
ivk93 K4-R 278–250 GGTTAAGTGTAACtTCCCATTCACTTCTC
*primers with internal mismatch or 59 tail that did not interfere with PCR amplification.
Mutations introduced by these primers are indicated in bold and lower case.
doi:10.1371/journal.pone.0064137.t001
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were transfected into subconfluent BSR-T7 cells in quadruplicate
reactions in 24-well plates based on the protocol described
previously ([11]). Each well was transfected with 80 ng each of
TM1-Fluc (internal control firefly luciferase), TM1-BUNN, TM1-
BUNL, and 1.6 ng of T7ribo-MRen (expressing the minigenome
containing the Renilla luciferase ORF in negative orientation
between M segment UTRs). Cells were co-transfected with pTM1-
derived plasmids (ranging from 1.6 to 160 ng per well) expressing
NSs, NSs4KR, or GFP as a negative control. The total amount of
DNA transfected was kept constant by the addition of empty TM1
vector. After 24 h of incubation Renilla luciferase activity was
measured in a luminometer using the Dual Luciferase Assay Kit
(Promega), and standardised to the levels of firefly luciferase.
Values were normalised to the control reaction where no NSs
protein was expressed.
DNA fragmentation assay
Analysis of DNA fragmentation, as a measure of apoptosis,
followed the method detailed by Kohl et al. ([9]).
Western Blotting (WB)
Detection of proteins by Western blotting was performed as
described previously ([44]) using the following antibodies: anti-
tubulin (1:5000; clone B512, Sigma), anti-BUNN (1:5000; ([35])),
anti-BUNNSs (1:500; ([8])), anti-NEDD8 (1:1000; Epitomics),
anti-rabbit IgG-HRP conjugate (1:5000; Cell Signalling), anti-
mouse IgG peroxidase conjugate (1:5000; Sigma). Typically,
exposures for N protein and tubulin were very short (5–15 sec),
whereas detection of NSs required much longer exposures ranging
from 2 to 30 min.
Northern Blotting (NB)
For RNA analysis of passaged viruses, the virions were pelleted
from 1 ml of supernatant by centrifugation in a benchtop
microfuge at 20,0006g for 1.5 h at 4uC. The pellets were
resuspended in 140 ml of PBS and the RNA was extracted using
the QiAmp viral RNA minikit (Qiagen). The yields of RNA varied
considerably but were not directly related to the level of signal of
the viral RNA segments. The amount of RNA to be loaded on the
gel was determined empirically and ranged from 0.8 to 3.8 mg per
lane. The RNA was separated by electrophoresis on a 1.5%
agarose/TAE gel, followed by capillary transfer in 10xSSC to a
positively charged nylon membrane. Viral genome-sense RNA
species of the L-segment were visualised by hybridysation to the
DIG-labelled L+ probe and detection by anti-DIG-HRP antibody
using the DIG Northern Starter Kit (Roche).
Virus sequencing
To determine the viral genome sequences after serial passage,
the virion RNA was extracted as described above. cDNA to the S
segment was synthesised using MMLV Reverse Transcriptase
(Promega) with primer ivk01, followed by PCR amplification using
KOD polymerase (Novagen) with primers ivk01+ ivk55 and
ivk02+ ivk20 (for all primers see Table 1). PCR products were
purified from agarose/TAE gels using Promega Wizard kit and
their sequence determined commercially (Dundee Sequencing
Service).
Mouse studies
Mouse infections were performed as described previously ([49]).
Strain 129/Sv(ev) were purchased from B&K Universal Ltd. Mice
were maintained in the Hugh Robson Building Animal Unit,
College of Medicine & Veterinary Medicine, University of
Edinburgh, UK, in specific-pathogen-free and environmentally
enriched conditions with food and water supplied ad libitum. All
experimental studies were agreed by the University of Edinburgh
Ethical Review Committee and were carried out under the
authority of UK Home Office licence 60/4112. Groups of six 4–
5 week old mice were anaesthitised and inoculated intracranially
with 20 ml PBS with 0.75% BSA (PBSA) containing 16103 PFU
wtBUNV or rBUN4KR virus. The mice were monitored twice
daily for up to two weeks and euthanized when displaying 4 or
more of the predefined moderate severity signs.
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